Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | LTA4H | P09960 | 1/20 | 0.46 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.42 |
| ▸ | HRH1 | P35367 | 1/20 | 0.41 |
| ▸ | TSPO | P30536 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.40 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.40 |
| ▸ | TLR4 | O00206 | 1/20 | 0.40 |
| ▸ | TLR2 | O60603 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL887945 | 0.96 | GAA (0.46) | GAALMNAKMT2APOLBTSHR | |
| SCHEMBL11337531 | 0.88 | GAA (0.46) | GAALMNAKMT2APOLBCTNNB1 | |
| SCHEMBL9166410 | 0.86 | GAA (0.39) | GAALMNAKMT2APOLBHTT | |
| SCHEMBL10640942 | 0.86 | PTGS2 (0.46) | GAALMNAKMT2APOLBTSHR | |
| SCHEMBL8498200 | 0.85 | FFAR1 (0.45) | GAALMNAKMT2APOLBHTT | |
| SCHEMBL887946 | 0.84 | GAA (0.43) | GAALMNAKMT2APOLBTSHR | |
| SCHEMBL8491438 | 0.84 | TRPA1 (0.46) | GAALMNAKMT2APOLBHTT | |
| SCHEMBL6508125 | 0.81 | CA4 (0.36) | GAALMNAKMT2APOLBTSHR | |
| SCHEMBL2748004 | 0.78 | GAA (0.47) | GAALMNAKMT2APOLBTSHR | |
| SCHEMBL1162713 | 0.78 | GAA (0.72) | GAALMNAKMT2APOLBTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 221 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102471494-B | star polymer | Robert Bosch Ltd. (DE) | 2015-11-25 | — | — | CN | claimed |
| US-9127129-B2 | Star polymer | ROBERT BOSCH GMBH (DE) | 2015-09-08 | — | — | US | claimed |
| US-8850985-B2 | Polymeric material suitable for making ammunition cartridge casings | SOLVAY ADVANCED POLYMERS, L.L.C. (US) | 2014-10-07 | — | — | US | claimed |
| US-20140235784-A1 | POLYMERIC MATERIAL SUITABLE FOR MAKING AMMUNITION CARTRIDGE CASINGS | SOLVAY ADVANCED POLYMERS, LLC. (US) | 2014-08-21 | — | — | US | claimed |
| US-20120238699-A1 | STAR POLYMER | ROBERT BOSCH GMBH (DE) | 2012-09-20 | — | — | US | claimed |
| US-8240252-B2 | Ammunition casing | U.S. GOVERNMENT AS REPRESENTED BY THE SECRETARY OF THE ARMY | 2012-08-14 | — | — | US | claimed |
| EP-2456812-A1 | STAR POLYMER | Robert Bosch GmbH (DE) | 2012-05-30 | — | — | EP | claimed |
| WO-2011009949-A1 | STAR POLYMER | ROBERT BOSCH GMBH (DE) | 2011-01-27 | — | — | WO | claimed |
| US-20100305261-A1 | POLYMERICA MATERIAL SUITABLE FOR MAKING AMMUNITION CARTRIDGE CASINGS | SOLVAY ADVANCED POLYMERS L.L.C. (US) | 2010-12-02 | — | — | US | claimed |
| US-20100099875-A1 | NEW ORTHO-FUNCTIONALIZED P-CHIRAL ARYLPHOSPHINES AND DERIVATIVES: THEIR PREPARATION AND USE IN ASYMMETRIC CATALYSIS | PHOSPHOENIX SARL (FR) | 2010-04-22 | — | — | US | claimed |
| US-5827927-A | Macromonomers having reactive end groups | MAXDEM INCORPORATED (US) | 1998-10-27 | — | — | US | claimed |
| US-5824744-A | RIGID POLYMER RODS AND MACROMONOMERS WITH REACTIVE END GROUPS FOR REINFORCEMENT | MAXDEM INCORPORATED (US) | 1998-10-20 | — | — | US | claimed |
| US-5756763-A | ENZYME INHIBITOR | ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYUKAI (JP) | 1998-05-26 | — | — | US | claimed |
| EP-0773249-A1 | Polyphenylene co-polymers | MAXDEM INCORPORATED (US) | 1997-05-14 | — | — | EP | claimed |
| EP-0709373-A1 | NOVEL PYRROLIDINE DERIVATIVE | ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) | 1996-05-01 | — | — | EP | claimed |
| US-5403675-A | Ion exchange structure having solid electrolyte of sulfonated rigid rod polyphenylene, electrodes; high proton conductivity | MAXDEM, INCORPORATED (US) | 1995-04-04 | — | — | US | claimed |
| WO-1994024717-A1 | SULFONATED POLYMERS FOR SOLID POLYMER ELECTROLYTES | MAXDEM INCORPORATED (US) | 1994-10-27 | — | — | WO | claimed |
| EP-0197788-B1 | PURIFICATION OF ACID HALIDES | RAYCHEM CORPORATION (a Delaware corporation) (US) | 1991-02-27 | — | — | EP | claimed |
| US-4314839-A | 1,2,3-Thiadiazole-5-carboxylic acid amide derivatives, process for making the same and herbicidal growth regulating defoliating and fungicidal compositions containing same | SCHERING AKTIENGESELLSCHAFT (DE) | 1982-02-09 | — | — | US | claimed |
| US-4198205-A | SULFONIC ACID-FREE DISPERSE DYES | BASF AKTIENGESELLSCHAFT (DE) | 1980-04-15 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100099875-A1 | NEW ORTHO-FUNCTIONALIZED P-CHIRAL ARYLPHOSPHINES AND DERIVATIVES: THEIR PREPARATION AND USE IN ASYMMETRIC CATALYSIS | PNP, NANP, PHOSPHO1 | GAA 2354/4885LMNA 4735/4885KMT2A 2556/4885 |
| US-20120238699-A1 | STAR POLYMER | STARD3, STARD10, STARD7 | GAA 1935/4885LMNA 1204/4885KMT2A 2905/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.